CoMET: a randomised controlled trial of co-commencement of metformin versus placebo as an adjunctive treatment to attenuate weight gain in patients with schizophrenia newly commenced on clozapine.
Dan J SiskindAnthony W RussellShuichi SuetaniDylan FlawsSteve KiselyVikas MoudgilKorinne NorthwoodGail RobinsonJames G ScottTerry StedmanNicola WarrenKarl WinckelPeter CosgroveAndrea BakerPublished in: Therapeutic advances in psychopharmacology (2021)
ACTRN12617001547336.